FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4366290734> ?p ?o ?g. }

• W4366290734 abstract "Introduction Holstein steers ( n = 32) were used to determine if the ergot analog, bromocriptine decreases muscle protein synthesis through inhibitory action on the mTOR pathway via a direct effect on signal proteins, and if these negative effects can be alleviated with anabolic agents. Methods Steers were treated with intramuscular administration of bromocriptine (vehicle or 0.1 mg/kg BW) and a subdermal commercial steroidal implant containing trenbolone acetate (TBA) and estradiol 17β (with or without), in a 2×2 factorial design. During the 35 day experiment, intake was restricted to 1.5 times maintenance energy requirement. On days 27 through 32, steers were moved to metabolism stalls for urine collection, and whole-body protein turnover was determined using a single pulse dose of [ 15 N] glycine into the jugular vein on day 28. On day 35, skeletal muscle samples were collected before (basal state) and 60 min after (stimulated state) an i.v. glucose challenge (0.25 g glucose/kg). Blood samples were collected at regular intervals before and after glucose infusion for determination of circulating concentrations of glucose and insulin. Results Bromocriptine reduced insulin and glucose clearance following the glucose challenge, indicating decreased insulin sensitivity and possible disruption of glucose uptake and metabolism in the skeletal muscle. Conversely, analysis of whole-body protein turnover demonstrated that bromocriptine does not appear to affect protein synthesis or urea excretion. Western immunoblot analysis of skeletal muscle showed that it did not affect abundance of S6K1 or 4E-BP1, so bromocriptine does not appear to inhibit activation of the mTOR pathway or protein synthesis. Estradiol/TBA implant decreased urea excretion and protein turnover but had no effect on protein synthesis, suggesting that steroidal implants promote protein accretion through unchanged rates of synthesis and decreased degradation, even in the presence of bromocriptine, resulting in improved daily gains. Implanted steers likely experienced increased IGF-1 signaling, but downstream activation of mTOR, S6K and 4E-BP1, and thus increased protein synthesis did not occur as expected. Conclusions Overall, this data suggests that bromocriptine does not have a negative impact on muscle protein synthetic pathways independent of DMI." @default.
• W4366290734 created "2023-04-20" @default.
• W4366290734 creator A5024794176 @default.
• W4366290734 creator A5037490591 @default.
• W4366290734 creator A5050030407 @default.
• W4366290734 creator A5058618228 @default.
• W4366290734 creator A5065786597 @default.
• W4366290734 creator A5083540252 @default.
• W4366290734 date "2023-04-18" @default.
• W4366290734 modified "2023-09-30" @default.
• W4366290734 title "Impact of ergot alkaloid and steroidal implant on whole-body protein turnover and expression of mTOR pathway proteins in muscle of cattle" @default.
• W4366290734 cites W1488053186 @default.
• W4366290734 cites W149131629 @default.
• W4366290734 cites W1540324495 @default.
• W4366290734 cites W1584861882 @default.
• W4366290734 cites W1870200437 @default.
• W4366290734 cites W1964042817 @default.
• W4366290734 cites W1971234080 @default.
• W4366290734 cites W1972466410 @default.
• W4366290734 cites W1972527462 @default.
• W4366290734 cites W1982121003 @default.
• W4366290734 cites W1998538796 @default.
• W4366290734 cites W1999856012 @default.
• W4366290734 cites W2001479739 @default.
• W4366290734 cites W2014574054 @default.
• W4366290734 cites W2017824471 @default.
• W4366290734 cites W2020260928 @default.
• W4366290734 cites W2031057942 @default.
• W4366290734 cites W2033616152 @default.
• W4366290734 cites W2034036456 @default.
• W4366290734 cites W203648266 @default.
• W4366290734 cites W2046406719 @default.
• W4366290734 cites W2057217173 @default.
• W4366290734 cites W2066583605 @default.
• W4366290734 cites W2069180490 @default.
• W4366290734 cites W2070089423 @default.
• W4366290734 cites W2071897998 @default.
• W4366290734 cites W2079363642 @default.
• W4366290734 cites W2081305406 @default.
• W4366290734 cites W2090131863 @default.
• W4366290734 cites W2092160214 @default.
• W4366290734 cites W2092713872 @default.
• W4366290734 cites W2103594906 @default.
• W4366290734 cites W2107114433 @default.
• W4366290734 cites W2110527130 @default.
• W4366290734 cites W2113103296 @default.
• W4366290734 cites W2114806810 @default.
• W4366290734 cites W2162539461 @default.
• W4366290734 cites W2169396440 @default.
• W4366290734 cites W2169769827 @default.
• W4366290734 cites W2171998960 @default.
• W4366290734 cites W218029137 @default.
• W4366290734 cites W2196957770 @default.
• W4366290734 cites W2200054998 @default.
• W4366290734 cites W220082507 @default.
• W4366290734 cites W2285870177 @default.
• W4366290734 cites W236703630 @default.
• W4366290734 cites W2405719715 @default.
• W4366290734 cites W2415278509 @default.
• W4366290734 cites W2420906432 @default.
• W4366290734 cites W2462471309 @default.
• W4366290734 cites W2590999575 @default.
• W4366290734 cites W2593816418 @default.
• W4366290734 cites W271757235 @default.
• W4366290734 cites W2757965705 @default.
• W4366290734 cites W2777469945 @default.
• W4366290734 cites W2884761694 @default.
• W4366290734 cites W2888248174 @default.
• W4366290734 cites W2897126943 @default.
• W4366290734 cites W302075130 @default.
• W4366290734 cites W3081448379 @default.
• W4366290734 cites W3085847714 @default.
• W4366290734 cites W312683571 @default.
• W4366290734 cites W4285742744 @default.
• W4366290734 cites W51912627 @default.
• W4366290734 cites W2288921737 @default.
• W4366290734 doi "https://doi.org/10.3389/fvets.2023.1104361" @default.
• W4366290734 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37143501" @default.
• W4366290734 hasPublicationYear "2023" @default.
• W4366290734 type Work @default.
• W4366290734 citedByCount "0" @default.
• W4366290734 crossrefType "journal-article" @default.
• W4366290734 hasAuthorship W4366290734A5024794176 @default.
• W4366290734 hasAuthorship W4366290734A5037490591 @default.
• W4366290734 hasAuthorship W4366290734A5050030407 @default.
• W4366290734 hasAuthorship W4366290734A5058618228 @default.
• W4366290734 hasAuthorship W4366290734A5065786597 @default.
• W4366290734 hasAuthorship W4366290734A5083540252 @default.
• W4366290734 hasBestOaLocation W43662907341 @default.
• W4366290734 hasConcept C1008401 @default.
• W4366290734 hasConcept C126322002 @default.
• W4366290734 hasConcept C134018914 @default.
• W4366290734 hasConcept C171089720 @default.
• W4366290734 hasConcept C185592680 @default.
• W4366290734 hasConcept C195580219 @default.
• W4366290734 hasConcept C2776856834 @default.
• W4366290734 hasConcept C2777866211 @default.
• W4366290734 hasConcept C2779064019 @default.
• W4366290734 hasConcept C2779306644 @default.
• W4366290734 hasConcept C2779959927 @default.

• next